Defibrotide Dose-escalation for SOS Post-HSCT
NCT05987124
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Sinusoidal Obstruction Syndrome
Veno-occlusive Disease
Interventions
DRUG:
Defibrotide
Sponsor
New York Medical College